| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 279.637 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 263.616 | 86 |
| GSM780709 | Untreated after 4 days (C3_1) | 223.628 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 244.741 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 267.79 | 86 |
| GSM780721 | Untreated after 4 days (C3_2) | 198.593 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 259.746 | 86 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 202.541 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 232.432 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 289.503 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 189.257 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 217.727 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 158.063 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 255.347 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 240.431 | 85 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 167.375 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 225.099 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 230.927 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 150.67 | 80 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 185.718 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 234.751 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 153.088 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 209.635 | 84 |